Impact of pharmacologic treatment for alcohol use disorder on mortality in patients with alcohol-associated liver disease: analysis from a United States insurance claims database

Key Points

• This research aims to evaluate the impact of pharmacologic treatment for alcohol use disorder on mortality in patients with alcohol-associated liver disease.
• Retrospective cohort study design
• Analysis of nationwide commercial insurance claims and Medicare supplemental data
• Patients identified with alcohol use disorder and liver disease
• Mortality rates compared before and after treatment initiation
• Patients receiving AUD treatment after hospitalization showed reduced mortality
• Association indicates a significant clinical benefit from pharmacologic treatment in managing liver disease